Neuroprotective effect of Betalain against AlCl3-induced Alzheimer's disease in Sprague Dawley Rats via putative modulation of oxidative stress and nuclear factor kappa B (NF-κB) signaling pathway

Alzheimer's disease (AD) is the most progressive form of neurodegenerative disease, which severely impairs cognitive function. Oxidative stress is identified to contribute to the mechanisms responsible for the pathogenesis of such neurodegenerative diseases. Aluminum is a potent neurotoxin for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicine & pharmacotherapy 2021-05, Vol.137, p.111369, Article 111369
Hauptverfasser: Shunan, Di, Yu, Miao, Guan, Huibo, Zhou, Yanyan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 111369
container_title Biomedicine & pharmacotherapy
container_volume 137
creator Shunan, Di
Yu, Miao
Guan, Huibo
Zhou, Yanyan
description Alzheimer's disease (AD) is the most progressive form of neurodegenerative disease, which severely impairs cognitive function. Oxidative stress is identified to contribute to the mechanisms responsible for the pathogenesis of such neurodegenerative diseases. Aluminum is a potent neurotoxin for inducing oxidative stress associated with neurodegenerative diseases. The treatment for AD is limited; hence more treatment options are the need of the day. Betalain is known for its multitude of medicinal assets, including anti-inflammatory activity. Hence, this study was intended to investigate the possible protective effect of betalain against aluminum chloride (AlCl3) induced AD on Sprague Dawley (SD) rats. AlCl3 (100 mg/kg) was administrated orally to induce the AD in SD rats. The rats were supplemented with low and high betalain doses (10 mg/kg and 20 mg/kg) for four weeks. At the end of the experiment, the rats were subjected to behavioral examination and sacrificed to study the biochemical and histological parameters. The results showed attenuation of memory and learning capacity, suppression of lipid oxidation (MDA) through regulation of antioxidant content (SOD, CAT, and GSH) and inhibition of lactate dehydrogenase (LDH), nitric oxide (NO), acetylcholinesterase (AChE), and transmembrane protein (Na+K+ATPase) activity. In addition, the NF-ƙB associated mRNA expression (TNF-α IL-6, Il-1β, iNOS, COX-2) was decreased, as evidenced in histopathological results. The present investigation established that the betalain treatment ameliorated the AlCl3 induced AD by modulating NF-κB pathway activation.
doi_str_mv 10.1016/j.biopha.2021.111369
format Article
fullrecord <record><control><sourceid>elsevier_webof</sourceid><recordid>TN_cdi_webofscience_primary_000634752600007CitationCount</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0753332221001542</els_id><doaj_id>oai_doaj_org_article_ef38bd905461419797959383c9959fed</doaj_id><sourcerecordid>S0753332221001542</sourcerecordid><originalsourceid>FETCH-LOGICAL-c517t-424b7e43ed95c6bbb20d1002ee1d096e5634f48e85ccf36a0ceee87673d96bbb3</originalsourceid><addsrcrecordid>eNqNUktvEzEQXiEQTQv_gINvgNAGe73PC1ITKFSqisTjbM3a48Rhs17Z3oT0p3Hnym_CyVY9ImTJHo_m--bxTZK8YHTOKCvfbuatscMa5hnN2JwxxsvmUTJjTUHTktLqcTKjVcFTzrPsLDn3fkMpLUpeP03OOC_qLC-yWfL7FkdnB2cDymB2SFDraBGryQIDdGB6Aqt4-0Auu2XHU9OrUaKKv7s1mi26l54o4xE8khj8dXCwGpG8h32HB_IFgic7A2QYA5wSbK0au2ja_pjE_jRq8vvg0HsCvSL9KDsERzTIYB35AcMAZEFe3V6lf34tXhNvVj10pl-RAcJ6D4dnyRMNncfn9-9F8v3qw7flp_Tm88fr5eVNKgtWhTTP8rbCnKNqClm2bZtRxSjNEJmiTYlxOrnOa6wLKTUvgUpErKuy4qo5hvOL5HriVRY2YnBmC-4gLBhxcli3EuCCidUL1LxuVUOLvGQ5a6p4iobXXDbx1agiVz5xSWe9d6gf-BgVR4XFRkwKi6PCYlI4wuoJtsfWai8N9hIfoFHi2ENVZHED4g4sTThNemnHPkTom_-Hxuh3UzTGge4MOnGPUMbFDYkdm39X-hefBdPT</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Neuroprotective effect of Betalain against AlCl3-induced Alzheimer's disease in Sprague Dawley Rats via putative modulation of oxidative stress and nuclear factor kappa B (NF-κB) signaling pathway</title><source>Elsevier ScienceDirect Journals Complete</source><source>Web of Science - Science Citation Index Expanded - 2021&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Shunan, Di ; Yu, Miao ; Guan, Huibo ; Zhou, Yanyan</creator><creatorcontrib>Shunan, Di ; Yu, Miao ; Guan, Huibo ; Zhou, Yanyan</creatorcontrib><description>Alzheimer's disease (AD) is the most progressive form of neurodegenerative disease, which severely impairs cognitive function. Oxidative stress is identified to contribute to the mechanisms responsible for the pathogenesis of such neurodegenerative diseases. Aluminum is a potent neurotoxin for inducing oxidative stress associated with neurodegenerative diseases. The treatment for AD is limited; hence more treatment options are the need of the day. Betalain is known for its multitude of medicinal assets, including anti-inflammatory activity. Hence, this study was intended to investigate the possible protective effect of betalain against aluminum chloride (AlCl3) induced AD on Sprague Dawley (SD) rats. AlCl3 (100 mg/kg) was administrated orally to induce the AD in SD rats. The rats were supplemented with low and high betalain doses (10 mg/kg and 20 mg/kg) for four weeks. At the end of the experiment, the rats were subjected to behavioral examination and sacrificed to study the biochemical and histological parameters. The results showed attenuation of memory and learning capacity, suppression of lipid oxidation (MDA) through regulation of antioxidant content (SOD, CAT, and GSH) and inhibition of lactate dehydrogenase (LDH), nitric oxide (NO), acetylcholinesterase (AChE), and transmembrane protein (Na+K+ATPase) activity. In addition, the NF-ƙB associated mRNA expression (TNF-α IL-6, Il-1β, iNOS, COX-2) was decreased, as evidenced in histopathological results. The present investigation established that the betalain treatment ameliorated the AlCl3 induced AD by modulating NF-κB pathway activation.</description><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2021.111369</identifier><identifier>PMID: 33582452</identifier><language>eng</language><publisher>ISSY-LES-MOULINEAUX: Elsevier Masson SAS</publisher><subject>Aluminium chloride (AlCl3) ; Alzheimer's disease (AD) ; Betalain ; Dementia ; Inflammation ; Life Sciences &amp; Biomedicine ; Medicine, Research &amp; Experimental ; Oxidative stress ; Pharmacology &amp; Pharmacy ; Research &amp; Experimental Medicine ; Science &amp; Technology</subject><ispartof>Biomedicine &amp; pharmacotherapy, 2021-05, Vol.137, p.111369, Article 111369</ispartof><rights>2021 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>53</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000634752600007</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c517t-424b7e43ed95c6bbb20d1002ee1d096e5634f48e85ccf36a0ceee87673d96bbb3</citedby><cites>FETCH-LOGICAL-c517t-424b7e43ed95c6bbb20d1002ee1d096e5634f48e85ccf36a0ceee87673d96bbb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.biopha.2021.111369$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>315,782,786,3552,27931,27932,39265,46002</link.rule.ids></links><search><creatorcontrib>Shunan, Di</creatorcontrib><creatorcontrib>Yu, Miao</creatorcontrib><creatorcontrib>Guan, Huibo</creatorcontrib><creatorcontrib>Zhou, Yanyan</creatorcontrib><title>Neuroprotective effect of Betalain against AlCl3-induced Alzheimer's disease in Sprague Dawley Rats via putative modulation of oxidative stress and nuclear factor kappa B (NF-κB) signaling pathway</title><title>Biomedicine &amp; pharmacotherapy</title><addtitle>BIOMED PHARMACOTHER</addtitle><description>Alzheimer's disease (AD) is the most progressive form of neurodegenerative disease, which severely impairs cognitive function. Oxidative stress is identified to contribute to the mechanisms responsible for the pathogenesis of such neurodegenerative diseases. Aluminum is a potent neurotoxin for inducing oxidative stress associated with neurodegenerative diseases. The treatment for AD is limited; hence more treatment options are the need of the day. Betalain is known for its multitude of medicinal assets, including anti-inflammatory activity. Hence, this study was intended to investigate the possible protective effect of betalain against aluminum chloride (AlCl3) induced AD on Sprague Dawley (SD) rats. AlCl3 (100 mg/kg) was administrated orally to induce the AD in SD rats. The rats were supplemented with low and high betalain doses (10 mg/kg and 20 mg/kg) for four weeks. At the end of the experiment, the rats were subjected to behavioral examination and sacrificed to study the biochemical and histological parameters. The results showed attenuation of memory and learning capacity, suppression of lipid oxidation (MDA) through regulation of antioxidant content (SOD, CAT, and GSH) and inhibition of lactate dehydrogenase (LDH), nitric oxide (NO), acetylcholinesterase (AChE), and transmembrane protein (Na+K+ATPase) activity. In addition, the NF-ƙB associated mRNA expression (TNF-α IL-6, Il-1β, iNOS, COX-2) was decreased, as evidenced in histopathological results. The present investigation established that the betalain treatment ameliorated the AlCl3 induced AD by modulating NF-κB pathway activation.</description><subject>Aluminium chloride (AlCl3)</subject><subject>Alzheimer's disease (AD)</subject><subject>Betalain</subject><subject>Dementia</subject><subject>Inflammation</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Medicine, Research &amp; Experimental</subject><subject>Oxidative stress</subject><subject>Pharmacology &amp; Pharmacy</subject><subject>Research &amp; Experimental Medicine</subject><subject>Science &amp; Technology</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>DOA</sourceid><recordid>eNqNUktvEzEQXiEQTQv_gINvgNAGe73PC1ITKFSqisTjbM3a48Rhs17Z3oT0p3Hnym_CyVY9ImTJHo_m--bxTZK8YHTOKCvfbuatscMa5hnN2JwxxsvmUTJjTUHTktLqcTKjVcFTzrPsLDn3fkMpLUpeP03OOC_qLC-yWfL7FkdnB2cDymB2SFDraBGryQIDdGB6Aqt4-0Auu2XHU9OrUaKKv7s1mi26l54o4xE8khj8dXCwGpG8h32HB_IFgic7A2QYA5wSbK0au2ja_pjE_jRq8vvg0HsCvSL9KDsERzTIYB35AcMAZEFe3V6lf34tXhNvVj10pl-RAcJ6D4dnyRMNncfn9-9F8v3qw7flp_Tm88fr5eVNKgtWhTTP8rbCnKNqClm2bZtRxSjNEJmiTYlxOrnOa6wLKTUvgUpErKuy4qo5hvOL5HriVRY2YnBmC-4gLBhxcli3EuCCidUL1LxuVUOLvGQ5a6p4iobXXDbx1agiVz5xSWe9d6gf-BgVR4XFRkwKi6PCYlI4wuoJtsfWai8N9hIfoFHi2ENVZHED4g4sTThNemnHPkTom_-Hxuh3UzTGge4MOnGPUMbFDYkdm39X-hefBdPT</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Shunan, Di</creator><creator>Yu, Miao</creator><creator>Guan, Huibo</creator><creator>Zhou, Yanyan</creator><general>Elsevier Masson SAS</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>202105</creationdate><title>Neuroprotective effect of Betalain against AlCl3-induced Alzheimer's disease in Sprague Dawley Rats via putative modulation of oxidative stress and nuclear factor kappa B (NF-κB) signaling pathway</title><author>Shunan, Di ; Yu, Miao ; Guan, Huibo ; Zhou, Yanyan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c517t-424b7e43ed95c6bbb20d1002ee1d096e5634f48e85ccf36a0ceee87673d96bbb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aluminium chloride (AlCl3)</topic><topic>Alzheimer's disease (AD)</topic><topic>Betalain</topic><topic>Dementia</topic><topic>Inflammation</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Medicine, Research &amp; Experimental</topic><topic>Oxidative stress</topic><topic>Pharmacology &amp; Pharmacy</topic><topic>Research &amp; Experimental Medicine</topic><topic>Science &amp; Technology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shunan, Di</creatorcontrib><creatorcontrib>Yu, Miao</creatorcontrib><creatorcontrib>Guan, Huibo</creatorcontrib><creatorcontrib>Zhou, Yanyan</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Biomedicine &amp; pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shunan, Di</au><au>Yu, Miao</au><au>Guan, Huibo</au><au>Zhou, Yanyan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroprotective effect of Betalain against AlCl3-induced Alzheimer's disease in Sprague Dawley Rats via putative modulation of oxidative stress and nuclear factor kappa B (NF-κB) signaling pathway</atitle><jtitle>Biomedicine &amp; pharmacotherapy</jtitle><stitle>BIOMED PHARMACOTHER</stitle><date>2021-05</date><risdate>2021</risdate><volume>137</volume><spage>111369</spage><pages>111369-</pages><artnum>111369</artnum><issn>0753-3322</issn><eissn>1950-6007</eissn><abstract>Alzheimer's disease (AD) is the most progressive form of neurodegenerative disease, which severely impairs cognitive function. Oxidative stress is identified to contribute to the mechanisms responsible for the pathogenesis of such neurodegenerative diseases. Aluminum is a potent neurotoxin for inducing oxidative stress associated with neurodegenerative diseases. The treatment for AD is limited; hence more treatment options are the need of the day. Betalain is known for its multitude of medicinal assets, including anti-inflammatory activity. Hence, this study was intended to investigate the possible protective effect of betalain against aluminum chloride (AlCl3) induced AD on Sprague Dawley (SD) rats. AlCl3 (100 mg/kg) was administrated orally to induce the AD in SD rats. The rats were supplemented with low and high betalain doses (10 mg/kg and 20 mg/kg) for four weeks. At the end of the experiment, the rats were subjected to behavioral examination and sacrificed to study the biochemical and histological parameters. The results showed attenuation of memory and learning capacity, suppression of lipid oxidation (MDA) through regulation of antioxidant content (SOD, CAT, and GSH) and inhibition of lactate dehydrogenase (LDH), nitric oxide (NO), acetylcholinesterase (AChE), and transmembrane protein (Na+K+ATPase) activity. In addition, the NF-ƙB associated mRNA expression (TNF-α IL-6, Il-1β, iNOS, COX-2) was decreased, as evidenced in histopathological results. The present investigation established that the betalain treatment ameliorated the AlCl3 induced AD by modulating NF-κB pathway activation.</abstract><cop>ISSY-LES-MOULINEAUX</cop><pub>Elsevier Masson SAS</pub><pmid>33582452</pmid><doi>10.1016/j.biopha.2021.111369</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0753-3322
ispartof Biomedicine & pharmacotherapy, 2021-05, Vol.137, p.111369, Article 111369
issn 0753-3322
1950-6007
language eng
recordid cdi_webofscience_primary_000634752600007CitationCount
source Elsevier ScienceDirect Journals Complete; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Aluminium chloride (AlCl3)
Alzheimer's disease (AD)
Betalain
Dementia
Inflammation
Life Sciences & Biomedicine
Medicine, Research & Experimental
Oxidative stress
Pharmacology & Pharmacy
Research & Experimental Medicine
Science & Technology
title Neuroprotective effect of Betalain against AlCl3-induced Alzheimer's disease in Sprague Dawley Rats via putative modulation of oxidative stress and nuclear factor kappa B (NF-κB) signaling pathway
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-09T06%3A52%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroprotective%20effect%20of%20Betalain%20against%20AlCl3-induced%20Alzheimer's%20disease%20in%20Sprague%20Dawley%20Rats%20via%20putative%20modulation%20of%20oxidative%20stress%20and%20nuclear%20factor%20kappa%20B%20(NF-%CE%BAB)%20signaling%20pathway&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Shunan,%20Di&rft.date=2021-05&rft.volume=137&rft.spage=111369&rft.pages=111369-&rft.artnum=111369&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2021.111369&rft_dat=%3Celsevier_webof%3ES0753332221001542%3C/elsevier_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33582452&rft_els_id=S0753332221001542&rft_doaj_id=oai_doaj_org_article_ef38bd905461419797959383c9959fed&rfr_iscdi=true